Resultados da pesquisa - Ada Azaryan

  • A mostrar 1 - 3 resultados de 3
Refinar resultados
  1. 1
    Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study

    Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study Por Peter Schäfer, Alan Kivitz, Jianglin Ma, Shimon Korish, Donna Sutherland, Li Li, Ada Azaryan, Jolanta Kosek, Mary Adams, Lori Capone, Eun Mi Hur, Douglas R. Hough, Garth E. Ringheim

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study

    Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study Por Martin Hutchings, Rogier Mous, Michael Roost Clausen, Peter Johnson, Kim Linton, Martine E.D. Chamuleau, David John Lewis, Anna Sureda, David Cunningham, Roberto S Oliveri, Brian Elliott, Dena DeMarco, Ada Azaryan, Christopher Chiu, Tommy Li, Kuo-mei Chen, Tahamtan Ahmadi, Pieternella J. Lugtenburg

    Publicado em 2021
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Phase I study of single-agent CC-292, a highly selective Brutons tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

    Phase I study of single-agent CC-292, a highly selective Brutons tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia Por Jennifer R. Brown, Wael A. Harb, B. T. Hill, Janice Gabrilove, Jeff P. Sharman, Marshall T. Schreeder, Paul M. Barr, James M. Foran, TP Miller, Jan A. Burger, Kevin R. Kelly, Daruka Mahadevan, Shuo Ma, Y. Li, Daniel W. Pierce, Elizabeth D. Barnett, Joseph E. Marine, Michele Miranda, Ada Azaryan, Xu Y, Pilar Nava-Parada, Jay Mei, Thomas J. Kipps

    Publicado em 2016
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: